Prominent small bowel Ga-67 uptake associated with Yersinial and tuberculous enterocolitis

M. Brophey, L. Lamki*, B. Barron, S. Shah

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The nuclear medicine evaluation of the immunocompromised patient with fever of unknown origin may include the use of either labeled leukocytes or Ga-67 citrate, or both, in the search for an infectious focus. In recent years, labeled leukocytes (In-111 or Tc-99m) seem to have been employed preferentially by some. This is especially the case when the abdomen is a suspected site of involvement because of the normal colonic excretion of gallium that may complicate the interpretation of this study. The authors present the case of an immunocompromised patient with the interesting scintigraphic pattern of diffuse large and small bowel uptake of gallium secondary to biopsy proven Yersinia and tuberculous enterocolitis. A review of the recent literature reveals only one other similar case in which Yersinial disease was detected by Ga-67 scintigraphy. The present case illustrates that gallium's avidity for the atypical, less pyogenic, opportunistic infections common in immunocompromised patients justifies its continued use in such settings and, specifically, whenever tuberculosis is suspected.

Original languageEnglish
Pages (from-to)107-110
Number of pages4
JournalClinical Nuclear Medicine
Issue number2
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Prominent small bowel Ga-67 uptake associated with Yersinial and tuberculous enterocolitis'. Together they form a unique fingerprint.

Cite this